| CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement | 09/12 09:00 | accesswire.com |
| CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference | 09/04 09:05 | accesswire.com |
| IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc. | 09/03 08:00 | globenewswire.com |
| CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar | 08/27 09:10 | accesswire.com |
| CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment | 08/22 09:15 | accesswire.com |
| CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results | 08/15 08:00 | accesswire.com |
| Why Is CNS Pharmaceuticals (CNSP) Stock Down 69% Today? | 07/30 12:03 | investorplace.com |
| CNS Pharmaceuticals Expands Pipeline with In-License of Late Stage, Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies | 07/30 07:00 | accesswire.com |
| CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO/ASCO CNS Cancer Conference | 07/25 09:05 | accesswire.com |
| CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series | 07/16 09:15 | accesswire.com |